Drug Shortage Report for TEVA-ACYCLOVIR
Report ID | 122712 |
Drug Identification Number | 02285967 |
Brand name | TEVA-ACYCLOVIR |
Common or Proper name | TEVA-ACYCLOVIR 400MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ACYCLOVIR |
Strength(s) | 400MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J05AB |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-08-20 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-01-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-01-14 | French | Compare |
v8 | 2021-01-14 | English | Compare |
v7 | 2021-01-07 | French | Compare |
v6 | 2021-01-07 | English | Compare |
v5 | 2020-10-01 | French | Compare |
v4 | 2020-10-01 | English | Compare |
v3 | 2020-08-21 | English | Compare |
v2 | 2020-08-20 | French | Compare |
v1 | 2020-08-20 | English | Compare |
Showing 1 to 9 of 9